Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

20.37
+1.699.05%
Post-market: 19.88-0.4900-2.41%16:20 EDT
Volume:2.10M
Turnover:41.80M
Market Cap:2.08B
PE:-2.20
High:20.51
Open:18.99
Low:18.50
Close:18.68
Loading ...

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey
·
17 Dec 2024

Bernstein Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
17 Dec 2024

BRIEF-Biohaven Reports Phase 1 Degrader Data; Announces NDA Submission For Troriluzole In SCA

Reuters
·
16 Dec 2024

BUZZ-Biohaven rises on positive early-stage antibody drug trial results

Reuters
·
16 Dec 2024

Biohaven Says BHV-1300 Achieves 'Deep Lowering' of Targeted IgG During Early-Stage Trial

MT Newswires Live
·
16 Dec 2024

Biohaven reports clinical, regulatory milestones across MoDE platform

TIPRANKS
·
16 Dec 2024

Biohaven Ltd - Bhv-1300 Safe and Well Tolerated in Phase 1

THOMSON REUTERS
·
16 Dec 2024

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted Igg Reductions in the Lowest Subcutaneous Dose Tested; Announces Nda Submission for Troriluzole in SCA and Provides Other Key Program Updates

THOMSON REUTERS
·
16 Dec 2024

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates

PR Newswire
·
16 Dec 2024

Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting

PR Newswire
·
06 Dec 2024

Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)

TIPRANKS
·
06 Dec 2024

Biohaven Price Target Raised to $61.00/Share From $58.00 by RBC Capital

Dow Jones
·
05 Dec 2024

RBC Raises Price Target on Biohaven to $61 From $58, Keeps Outperform, Speculative Risk

MT Newswires Live
·
04 Dec 2024

Biohaven Ltd : RBC Raises Target Price to $61 From $58

THOMSON REUTERS
·
04 Dec 2024

Jefferies Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)

TIPRANKS
·
26 Nov 2024

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Vigil Neuroscience Inc (VIGL) and Biohaven Ltd. (BHVN)

TIPRANKS
·
26 Nov 2024

Biohaven Price Target Maintained With a $59.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Nov 2024

Biohaven Is Maintained at Outperform by RBC Capital

Dow Jones
·
26 Nov 2024

Biohaven study had positive signal for obesity, says H.C. Wainwright

TIPRANKS
·
26 Nov 2024

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study

Benzinga
·
26 Nov 2024